Lack of essential asthma medications in primary care centres in Kuwait

Affiliations

03 January 2003


Abstract

Setting: Asthma is a common chronic disease that can affect any age group. Available, affordable and effective asthma medications are essential to achieve good asthma control.

Objectives: To determine the availability of essential asthma medications in primary care centres and the cost of a year's supply in Kuwait.

Methods: A telephone survey was conducted in 36 centres. The cost of asthma medication was calculated based on estimated annual needs for the different grades of asthma severity.

Results: None of the centres surveyed had adequate asthma medication: 12 (33%) had just adequate and 24 (67%) had below adequate supplies. All had intravenous hydrocortisone and nebulised bronchodilators, but none had high-dose inhaled steroids; 24 (67%) had neither oral steroids nor salbutamol inhalers. All had oral bronchodilators, aminophylline and theophylline. Family medical centres had more asthma medications. The annual cost of treating a case of moderate asthma in Kuwait is 562 US dollars.

Conclusion: Most of the primary care centres in Kuwait lack essential asthma medications. This creates over-reliance on hospital emergency departments and affects asthma management.


Similar articles

Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries.

Aït-Khaled N, Auregan G, Bencharif N, Camara LM, Dagli E, Djankine K, Keita B, Ky C, Mahi S, Ngoran K, Pham DL, Sow O, Yousser M, Zidouni N, Enarson DA.Int J Tuberc Lung Dis. 2000 Mar;4(3):268-71.PMID: 10751075

Paediatric acute asthma management in Australia and New Zealand: practice patterns in the context of clinical practice guidelines.

Babl FE, Sheriff N, Borland M, Acworth J, Neutze J, Krieser D, Ngo P, Schutz J, Thomson F, Cotterell E, Jamison S, Francis P.Arch Dis Child. 2008 Apr;93(4):307-12. doi: 10.1136/adc.2007.125062.PMID: 18356383

Availability, price and affordability of asthma medicines in five Indian states.

Kotwani A.Int J Tuberc Lung Dis. 2009 May;13(5):574-9.PMID: 19383189

Access to inhaled corticosteroids is key to improving quality of care for asthma in developing countries.

Ait-Khaled N, Enarson DA, Bissell K, Billo NE.Allergy. 2007 Mar;62(3):230-6. doi: 10.1111/j.1398-9995.2007.01326.x.PMID: 17298339 Review.

[Introduction to asthma and chronic obstructive pulmonary disease pharmacoeconomics].

Jahnz-Rózyk K.Pol Merkur Lekarski. 2004 May;16 Suppl 1:5-6, 8.PMID: 15524004 Review. Polish.


Cited by

Fatal and near-fatal thunderstorm asthma epidemic in a desert country.

Ali F, Behbehani N, Alomair N, Taher A.Ann Thorac Med. 2019 Apr-Jun;14(2):155-160. doi: 10.4103/atm.ATM_258_18.PMID: 31007768 Free PMC article.

Costs associated with management of non-communicable diseases in the Arab Region: a scoping review.

Saleh S, El Harakeh A, Baroud M, Zeineddine N, Farah A, Sibai AM.J Glob Health. 2018 Dec;8(2):020410. doi: 10.7189/jogh.08.020410.PMID: 30546867 Free PMC article. Review.

Evaluation of drug use practices at primary healthcare centers of Kuwait.

Awad A, Al-Saffar N.Eur J Clin Pharmacol. 2010 Dec;66(12):1247-55. doi: 10.1007/s00228-010-0872-8. Epub 2010 Jul 29.PMID: 20669012


KMEL References